The illustrious GP from Otago is Macquarie's "gun" healthcare analyst, so therefore someone to be heeded when analysing new,ground-breaking stem cell therapies. He is fighting the good fight but does tend to manipulate data to suit his own transparent purposes, in my view. Rather comical at times with his churlish rejection of valid data released by MSB but hey, it's a free world and we all have to make a living!
Ann: MSB Partner JCR Files for Product Approval, page-59
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.35 |
Change
0.105(8.43%) |
Mkt cap ! $1.541B | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.40 | $1.27 | $16.46M | 12.22M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 59739 | $1.35 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.36 | 5000 | 1 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |